Interleukin-6 receptor antagonist as therapy for rheumatoid arthritis
- PMID: 17969944
Interleukin-6 receptor antagonist as therapy for rheumatoid arthritis
Comment on
-
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.Arthritis Rheum. 2006 Sep;54(9):2817-29. doi: 10.1002/art.22033. Arthritis Rheum. 2006. PMID: 16947782 Clinical Trial.
References
Publication types
LinkOut - more resources
Research Materials